Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IGF2BP2 pseudogene 2 (IGF2BP2P2) is a non-coding pseudogene related to IGF2BP2, found in the human genome. Pseudogenes are DNA sequences similar to known genes but typically non-functional due to mutations or lack of regulatory elements. IGF2BP2P2 does not encode a protein and is not considered a receptor, enzyme, or other conventional drug target. Information on its function, disease roles, or use in therapy is absent. Its parent, IGF2BP2, is a well-studied RNA-binding protein involved in metabolic regulation and cancer, but IGF2BP2P2 itself is not functionally characterized as a molecular target. The search results and gene databases classify IGF2BP2P2 as a pseudogene, meaning it is not transcribed into a functional protein and does not meet criteria for a canonical therapeutic target.
No mechanism of drug action, as it is not an actionable gene/protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Insulin-like growth factor 2 mRNA-binding protein 2 pseudogene 2 (IGF2BP2P2).